[Inflammation of multiple seborrheic keratoses induced by chemotherapy with gemcitabine].
There are several common mucocutaneous adverse effects related to chemotherapy, either by direct cytotoxic action or by hypersensitivity to the drugs. The authors report inflammation in multiple seborrheic keratoses after chemotherapy with gemcitabine in a patient under treatment for pancreatic cancer. Moreover, they discuss the relative benignity of this event and warn about the need to correctly identify systemic chemotherapy-induced skin adverse effects.
Siqueira
Caio Roberto Shwafaty de
CR
Sociedade Brasileira de Dermatologia. caioshwafaty@yahoo.com
Miot
Hélio Amante
HA
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives*; D003875:Drug Eruptions / Q000150:complications* / Q000209:etiology*; D005260:Female; D006801:Humans; D017492:Keratosis, Seborrheic / Q000139:chemically induced* / Q000150:complications*; D008875:Middle Aged; D000093542:Gemcitabine
D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D000093542:Gemcitabine